Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Cooke

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 5, 2020
Do Coordinated Knowledge Translation Campaigns Persuade Radiation Oncologists to Use Single-Fraction Radiation Therapy Compared With Multiple-Fraction Radiation Therapy for Bone Metastases?Shaheer Shahhat, Nikesh Hanumanthappa, Youn Tae Chung, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 9, 2020
Work Group Report: Perspectives in Diagnosis and Management of Exercise-Induced Bronchoconstriction in AthletesJustin Greiwe, Andrew Cooke, Anil Nanda, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Do Sustainable Palliative Single Fraction Radiotherapy Practices Proliferate or Perish 2 Years after a Knowledge Translation Campaign?Shaheer Shahhat, Nikesh Hanumanthappa, Youn Tae Chung, et al.
Scientific Reports|March 3, 2026
Targeted supplementation with bioactive plants sustainably improves goat health and decreases antiparasitic drug use on smallholder farmsHonest Machekano, Javier Ventura-Cordero, Paul M Airs, et al.
Molecular Cancer Therapeutics|August 3, 2007
A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivoQun-sheng Ji, Mark J Mulvihill, Maryland Rosenfeld-Franklin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 24, 2020
Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and UptakeJulian O Kim, Daniel J Schaid, Celine M Vachon, et al.
Bioorganic & Medicinal Chemistry Letters|January 16, 2013
Discovery of potent, selective and orally bioavailable imidazo[1,5-a]pyrazine derived ACK1 inhibitorsMeizhong Jin, Jing Wang, Andrew Kleinberg, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2013
Discovery of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1: optimization of kinase selectivity and pharmacokineticsKeith R Hornberger, Xin Chen, Andrew P Crew, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Potent and selective [2-imidazol-1-yl-2-(6-alkoxy-naphthalen-2-yl)-1-methyl-ethyl]-dimethyl-amines as retinoic acid metabolic blocking agents (RAMBAs)Mark J Mulvihill, Julie L C Kan, Patricia Beck, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2006
1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitorsMark J Mulvihill, Qun-Sheng Ji, Doug Werner, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|September 5, 2020
Do Coordinated Knowledge Translation Campaigns Persuade Radiation Oncologists to Use Single-Fraction Radiation Therapy Compared With Multiple-Fraction Radiation Therapy for Bone Metastases?Shaheer Shahhat, Nikesh Hanumanthappa, Youn Tae Chung, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 9, 2020
Work Group Report: Perspectives in Diagnosis and Management of Exercise-Induced Bronchoconstriction in AthletesJustin Greiwe, Andrew Cooke, Anil Nanda, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
Do Sustainable Palliative Single Fraction Radiotherapy Practices Proliferate or Perish 2 Years after a Knowledge Translation Campaign?Shaheer Shahhat, Nikesh Hanumanthappa, Youn Tae Chung, et al.
Scientific Reports|March 3, 2026
Targeted supplementation with bioactive plants sustainably improves goat health and decreases antiparasitic drug use on smallholder farmsHonest Machekano, Javier Ventura-Cordero, Paul M Airs, et al.
Molecular Cancer Therapeutics|August 3, 2007
A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivoQun-sheng Ji, Mark J Mulvihill, Maryland Rosenfeld-Franklin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|October 24, 2020
Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and UptakeJulian O Kim, Daniel J Schaid, Celine M Vachon, et al.
Bioorganic & Medicinal Chemistry Letters|January 16, 2013
Discovery of potent, selective and orally bioavailable imidazo[1,5-a]pyrazine derived ACK1 inhibitorsMeizhong Jin, Jing Wang, Andrew Kleinberg, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2013
Discovery of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1: optimization of kinase selectivity and pharmacokineticsKeith R Hornberger, Xin Chen, Andrew P Crew, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2005
Potent and selective [2-imidazol-1-yl-2-(6-alkoxy-naphthalen-2-yl)-1-methyl-ethyl]-dimethyl-amines as retinoic acid metabolic blocking agents (RAMBAs)Mark J Mulvihill, Julie L C Kan, Patricia Beck, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2006
1,3-Disubstituted-imidazo[1,5-a]pyrazines as insulin-like growth-factor-I receptor (IGF-IR) inhibitorsMark J Mulvihill, Qun-Sheng Ji, Doug Werner, et al.
Pageof 7